Program Signaling by Specialty — ERAS & NRMP Data

What Is Program Signaling and Why It Matters

ERAS program signaling is a structured mechanism that lets applicants attach a limited number of formal interest designations—Gold signals and Silver signals—to selected programs before or at the time of application submission. Programs see which tier of signal, if any, they received. The signal carries no automatic action; it is a data point layered on top of the rest of your application.

The rationale is straightforward: application volume per program grew sharply in the years before signaling launched, creating screening problems on both sides. Programs buried in thousands of applications could not meaningfully review each one. Applicants received fewer interviews relative to applications sent. Signaling was introduced as a mutual filtering mechanism—applicants disclose genuine preference, programs use that information to calibrate screening thresholds.

Signal allocation decisions are consequential for two reasons. First, the limits are strict and non-replenishable; once a signal is submitted, it cannot be reassigned. Second, across most specialties, signaled applicants receive interview invitations at measurably higher rates than unsignaled applicants at the same programs. The gap is not uniform—it varies substantially by specialty, program prestige tier, and applicant competitiveness—but it is large enough in several fields that misallocating signals materially reduces interview yield. This page exists to give you the numbers and the allocation logic to avoid that outcome.

How Signal Limits Are Set by Specialty

Signal limits are set at the specialty level through a process involving specialty-specific governing bodies in coordination with AAMC. Limits are calibrated against typical application list lengths for each field; a specialty where applicants routinely apply to many programs receives a larger signal budget than one where lists are short. Limits can change season to season; always confirm current limits in ERAS at the time you apply.

The current architecture uses two tiers:

• Gold signals — the higher-priority designation. Programs interpret a Gold signal as your strongest declared preference within the specialty. The per-applicant Gold limit is the smaller of the two budgets.
• Silver signals — a secondary interest designation. The Silver budget is larger than Gold in most specialties, giving applicants room to mark a broader set of programs as genuine targets without exhausting the top-tier designation.

The table below reflects figures published by AAMC for the 2024–2025 application cycle (AAMC ERAS Signaling Program data, 2024). Because limits are subject to revision each cycle, treat this table as a verified historical reference and confirm current-season values in your ERAS applicant portal.

Signal Limits by Participating Specialty — 2024–2025 Cycle

Source: AAMC ERAS Preference Signaling Program, specialty-specific limit tables, 2024–2025 application cycle. Data year: 2024. Figures are per-applicant maximums; unused signals do not carry over.

Several competitive specialties—Dermatology, Orthopedic Surgery, and Plastic Surgery—carry a lower Gold limit (3) paired with a larger Silver allocation (30). This reflects specialty-level decisions that the Gold designation should be reserved for a very short list of top preferences. Applicants in those fields should treat each Gold signal as a high-stakes decision.

Not every ERAS specialty participates in signaling. Participation is opt-in at the specialty level and expands incrementally. Confirm participation status for any specialty not listed above directly in ERAS; the absence of a specialty from this table means it had not adopted signaling as of the 2024–2025 cycle, not that it is ineligible in future cycles.

Signal Acceptance Rates by Specialty (Current Season)

Source: AAMC ERAS Preference Signaling Program survey data and post-cycle reports, 2023–2024 and 2024–2025 application cycles. "Interview invitation rate" = proportion of signaled applicants at a given program who received an interview invitation from that program. Figures reflect aggregate averages; individual program behavior varies. Data year: 2023–2024 cycle (most recent published post-cycle figures as of this writing). Verify updated figures at AAMC's ERAS Signaling resource page each season.

AAMC publishes post-cycle data on interview invitation rates for signaled versus unsignaled applicants. The headline finding across cycles: Gold-signaled applicants receive interview invitations at substantially higher rates than unsignaled applicants, with Silver-signaled applicants in an intermediate position. However, specialty-level variation is large.

Approximate Interview Invitation Rates — Signaled vs. Unsignaled (2023–2024 Cycle, AAMC)

The following figures are drawn from AAMC's published signaling data for the 2023–2024 application cycle. Because AAMC reports these as ranges and averages rather than uniform point estimates, they are presented as approximate ranges.

• Dermatology — Gold-signaled applicants: invitation rate roughly 2–3× that of unsignaled applicants at the same programs. Silver-signaled: intermediate, approximately 1.5×. (AAMC, 2023–2024 cycle)
• Orthopedic Surgery — Gold-signaled: elevated invitation rate versus unsignaled, with the gap widening at programs receiving high application volume. (AAMC, 2023–2024 cycle)
• Internal Medicine — Gold and Silver signals both associated with higher invitation rates; the absolute gap between signaled and unsignaled is narrower than in highly competitive specialties, reflecting larger program capacity and higher baseline invitation rates. (AAMC, 2023–2024 cycle)
• Family Medicine — Signal effect present but smaller in magnitude; programs in this specialty tend to have higher baseline invitation rates, compressing the relative difference. (AAMC, 2023–2024 cycle)
• Emergency Medicine — Moderate signal effect; Gold signals show a more consistent lift than Silver, which is closer to unsignaled rates at programs with large applicant pools. (AAMC, 2023–2024 cycle)
• General Surgery — Gold signals show a meaningful invitation rate advantage, particularly at higher-volume programs. (AAMC, 2023–2024 cycle)
• Psychiatry, Neurology, Pediatrics — Signal-associated invitation rate lift is present but generally smaller than in surgical specialties; the baseline invitation rate in these fields is higher, which arithmetically constrains the relative advantage. (AAMC, 2023–2024 cycle)

The practical implication: in specialties where the baseline interview invitation rate is already high (many applicants receive invitations with or without signals), the marginal value of any single signal is lower. In specialties where programs are highly selective relative to applicant volume—Dermatology, Orthopedic Surgery, Plastic Surgery, Neurological Surgery—the marginal value of a correctly placed Gold signal is higher because unsignaled applicants face a more severe screening disadvantage.

Interview Yield: Signaled vs. Unsignaled Programs

Source: AAMC ERAS Preference Signaling Program post-cycle reports, 2022–2023 and 2023–2024 cycles. "Interview yield" here means interviews received per application submitted to programs in a given signal category. Data year: 2023–2024 cycle.

AAMC's comparative data consistently shows a directional pattern: applicants who signal a program receive interview invitations from that program at a higher rate than applicants who do not signal. The magnitude differs by specialty and applicant profile.

Key calibration points from published AAMC data:

• Across all signaling specialties in the 2023–2024 cycle, Gold-signaled programs yielded interview invitations at roughly double the rate of unsignaled programs in the same application list, on a per-program basis. (AAMC, 2023–2024)
• Silver-signaled programs showed a yield advantage over unsignaled programs, though smaller in magnitude than Gold. The Silver advantage was most pronounced in competitive specialties with large applicant pools per program seat. (AAMC, 2023–2024)
• The yield advantage is not uniform across program prestige tiers. Some highly selective programs grant interviews at similar rates regardless of signal status, because their screening criteria center on other application components. This is why signals are not a substitute for a competitive application—they function as a tiebreaker and attention-directing mechanism, not an override of core review criteria.
• Programs that explicitly structure their screening workflow around signals—using signal receipt as a first-pass filter before detailed review—produce the largest yield differentials. Program director survey data (see section below) indicates this practice is common in competitive specialties but not universal.

For applicants building application lists: the yield data support concentrating signals on programs where you have genuine interest and a plausible competitiveness argument, not on programs where you are applying defensively or aspirationally beyond your profile. A Gold signal to a program that would screen you out on Step scores or other criteria before reviewing the signal provides minimal marginal yield benefit.

Signal Usage Patterns Across Applicants

Source: AAMC Applicant Survey and ERAS Signaling Program usage data, 2023–2024 application cycle. Data year: 2023–2024.

AAMC collects post-cycle data on how applicants actually use their signal allocations. Documented patterns from the 2023–2024 cycle:

• Gold signal utilization rate is high. The large majority of applicants in signaling specialties used all or nearly all of their Gold signals. Leaving Gold signals unused is the exception. (AAMC, 2023–2024)
• Silver signal utilization is more variable. A meaningful proportion of applicants in specialties with larger Silver budgets (e.g., 30 Silver signals) did not use their full allocation, often because their application list was shorter than the Silver budget. This is not inherently a mistake—signaling programs you do not genuinely plan to rank is a misuse of the mechanism—but it sometimes reflects under-application rather than deliberate strategy. (AAMC, 2023–2024)
• Geographic concentration is common. Applicants tend to cluster signals in specific geographic regions, consistent with lifestyle and personal constraint data. The risk is over-concentration: if a region has fewer participating programs than your signal budget, you may leave signals unused while missing programs elsewhere where you would realistically train.
• Signal allocation decisions are made early and often not revised. Because signals submit at the time of or shortly after application submission, many applicants finalize allocations with incomplete information about program participation or the current cycle's competitive landscape. Doing this research before the application window opens reduces last-minute allocation errors.

One pattern in the data worth flagging: applicants with shorter application lists sometimes signal a high proportion of their listed programs, including programs where they have low realistic probability of screening past other criteria. This dilutes the signaling signal—programs that receive signals from every applicant in a subset learn less from the signal than programs where signaling is more selective. The value of the mechanism depends partly on applicants using it to convey genuine, differentiated preference.

How to Allocate Signals Strategically by Specialty Category

Signal allocation strategy differs meaningfully across specialty categories. The following frameworks are organized by the structural features of each category, not by prestige ranking.

High-Competition, Small-Program-Count Specialties (Dermatology, Plastic Surgery, Orthopedic Surgery)

These fields have smaller total program counts, lower Gold limits (3 in the current cycle), and higher applicant-to-seat ratios. Every Gold signal is a significant decision.

• Reserve Gold signals for programs where you have a concrete connection or strong competitiveness argument: home institution, away rotation site, or programs whose publicly available profile closely matches your research or clinical focus.
• Use Silver signals for your realistic target tier—programs where your application profile is competitive but you have no specific relationship. Do not use Silver for aspirational reaches where you have no plausible screening basis.
• Geographic targeting: in these specialties, geographic flexibility tends to increase interview yield more than in larger specialties. If you are constrained to one region with few programs, your Silver budget may exceed available programs; apply the unused signals to programs in proximate regions you could realistically attend.
• Programs that don't participate in signaling are still worth applying to if they fit your list; absence of a signal mechanism does not depress your odds more than baseline.

Large, Distributed Specialties (Internal Medicine, Family Medicine, Pediatrics, Psychiatry)

These fields have large program counts, higher baseline invitation rates, and larger applicant pipelines including substantial IMG participation. The signal effect exists but is proportionally smaller.

• Gold signals are best used for programs with specific academic or geographic priority for you—programs you would rank first if invited. Using all 5 Gold signals at programs you would rank near the bottom of a long list wastes the designation's communicative value.
• Silver signals can reasonably cover the bulk of your target-tier list. Given large program counts, you may still have more realistic target programs than Silver budget allows; prioritize by match between your application strengths and program stated priorities.
• In family medicine specifically, where community programs are numerous and application lists can be long, signals help programs identify applicants who genuinely want to train in that region or program type. Geographic and mission alignment is a more useful signal allocation criterion here than in specialties where prestige-tier targeting dominates.

Mid-Size Competitive Specialties (General Surgery, Emergency Medicine, Anesthesiology, OB-GYN, Radiology)

These fields sit between the two poles: program counts are moderate, competition is meaningful, and signals carry a real yield effect without the extreme scarcity of the smallest fields.

• Gold signals should reflect genuine top-preference programs. Five Gold signals across a list of, say, 60–80 applications is a tight budget; identify your actual top 5 and be deliberate.
• Silver signals are your main coverage tool. Map your Silver budget against your realistic target list and allocate to programs where interview yield matters most to your rank list construction.
• For applicants with application file features that some programs weight heavily in screening (Step score below specialty norms, gaps, IMG status), signals may carry additional relative weight—they create an affirmative reason for a program to open your file before screening on other criteria. This is an argument for using signals precisely, not an argument for over-signaling reaches.

Small-Volume Specialties (Radiation Oncology, Thoracic Surgery, Vascular Surgery, Neurological Surgery)

Small total program counts mean your signal budget may exceed the number of programs you can realistically list. In this situation:

• Signal every program on your list where you have genuine interest and participation is confirmed. Running out of reasonable programs to signal before exhausting your budget is the expected outcome in some of these fields.
• Do not manufacture signals for programs you have no intent to attend just to use the budget. Unused signals do not penalize you.

Program Perspective: How Programs Interpret Signals

Source: NRMP Program Director Survey, most recent available edition. The NRMP conducts this survey periodically; cite the edition year when referencing specific figures. Data year: 2022–2023 NRMP Program Director Survey (most recent edition with signaling-specific questions as of this writing). Verify whether an updated edition has been released at nrmp.org before your application cycle.

Program directors across specialties report using signals in meaningfully different ways. The NRMP Program Director Survey provides the most systematic cross-specialty evidence on this question.

• Signals as a screening trigger, not a score. The most common reported use of signals is as a first-pass filter: programs use signal receipt to identify applicants to review first, or to set a lower application-review threshold for signaled files. This is distinct from using a signal to directly boost rank-list position—most program directors report that the signal influences whether they read your file carefully, not where they rank you after interview. (NRMP PD Survey)
• Specialty variation in signal weight. Program directors in highly competitive specialties (surgical fields, Dermatology) report placing relatively higher weight on signals compared to directors in larger primary care fields, consistent with the quantitative yield data. In fields where programs receive large application volumes relative to interview slots, any filter—including signals—has higher decision leverage. (NRMP PD Survey)
• Gold vs. Silver differentiation. A portion of program directors report treating Gold and Silver signals differently in their screening workflow; others treat any signal as a single binary indicator. The proportion making the Gold/Silver distinction is higher in competitive specialties. Applicants should not assume all programs weight the tiers differently, but should assume some do—which argues for not using Gold signals on programs where Silver would be the honest designation. (NRMP PD Survey)
• Signals versus other application components. Across specialties, program directors consistently rank signals as a secondary factor relative to letters of recommendation, clinical experience, and board scores. The signal functions as a multiplier on a file that is already reviewable—it increases the probability your file gets full attention, but it does not substitute for the components that drive interview-to-rank-list conversion. (NRMP PD Survey)

Common Signaling Mistakes and How to Avoid Them

The following are documented patterns—from AAMC usage data and program director feedback—that reduce signal yield without strategic justification.

Signaling Programs That Screen You Out on Other Criteria First

If a program's publicly stated or informally known screening thresholds (Step scores, degree type, USMLE attempt limits) mean your application is unlikely to advance past automated or first-pass filtering, a signal does not override that filter. The signal increases the probability your file is opened; it cannot change what the reviewer finds. Allocate signals to programs where your file is competitive enough that increased attention translates to an interview, not just a second look before rejection.

Under-Signaling Your Realistic Target Tier

Some applicants concentrate signals heavily on aspirational programs and apply to a larger set of realistic targets without signals. This is a yield-negative strategy: the programs most likely to invite you receive no signal, while programs least likely to invite you consume your high-value allocation. A more productive frame: signal the programs you most want to attend from among those where you are genuinely competitive. Your reach programs may not need a signal to decide—they will decide on the rest of your file.

Geographic Over-Concentration

Concentrating all signals in one metro area or region works if that region has enough participating programs to absorb your budget and your application list is geographically coherent. It is a problem when the region has fewer programs than your signal count, forcing you to either signal programs you rank low or leave signals unused. Map your signal budget against actual program geography before submission.

Signaling Programs That Don't Participate

ERAS signaling is opt-in at the specialty and program level. Submitting an application to a program that does not participate in signaling means no signal is transmitted regardless of your allocation. Confirm program participation status in ERAS before finalizing your signal list. Do not assume all programs in a participating specialty are individually enrolled.

Saving Signals for Later

Signals are submitted at application time within the defined submission window. They cannot be added to a program after the deadline has passed, and they do not accumulate across cycles. If you are uncertain about a program, decide before the deadline—there is no mechanism to signal retroactively based on new information received after submission.

Using Gold Signals on Programs You Would Not Highly Rank

If program directors in your specialty differentiate Gold from Silver, using a Gold signal on a program you would rank 20th on your eventual rank list is a misrepresentation that provides no strategic benefit and may consume a signal better placed elsewhere. Use Gold signals to communicate your actual top preferences.

Signal Deadlines and Technical Steps in ERAS

For current-season signal submission deadlines, see the current season timeline on this site. AAMC publishes the official signal submission window in the ERAS applicant portal and in ERAS communications; those are the authoritative dates.

Signal Submission Workflow in ERAS

1. Confirm specialty participation. Before building your signal list, verify that your specialty participates in signaling for the current cycle and check the Gold and Silver limits in your ERAS applicant portal. Limits are displayed within the signaling section of the application.
2. Identify participating programs. Within the signaling interface, programs that accept signals are identified. Not all programs in a participating specialty may be individually enrolled; the portal will indicate which programs are signal-eligible.
3. Assign signal tier to each program. For each program you elect to signal, designate Gold or Silver. The interface tracks your remaining Gold and Silver budget in real time. You can adjust assignments before final submission as long as the window is open.
4. Submit signals. Signals are submitted as part of the application or within the defined signal submission window. Review your assignments before submitting—post-deadline changes are not available.
5. Confirm receipt. After submission, ERAS provides a confirmation of signal transmission. Programs can see the signal designation in your application file; they do not see how many total signals you submitted, how many remain unused, or which other programs you signaled.
6. Unused signals. Signals not submitted before the deadline are forfeited. They do not convert, carry over to another cycle, or provide any alternative benefit. If your application list is shorter than your signal budget, it is expected and acceptable to not use your full allocation.

What Happens If a New Program Opens After Signal Submission

Programs that open after the signal submission deadline are generally not signal-eligible for that cycle under the current ERAS architecture. If you add a program to your list after signals close, that program receives no signal from you regardless of your remaining budget. This is not penalizing—programs that open late in a cycle typically understand the timing context. There is no mechanism to retroactively signal a program added after the deadline.

Specialty Deep-Dive Tables

Source: AAMC ERAS Signaling Program specialty-specific data, 2024–2025 application cycle; NRMP Match data, 2024 Main Residency Match. "Median programs applied to" reflects NRMP-published applicant data for matched and unmatched applicants combined where available; figures vary by applicant type (MD, DO, IMG). Data year: 2024. Verify current figures at aamc.org/eras and nrmp.org before your application cycle.

The following table is a consolidated reference. "Signal yield rate (Gold)" is an approximate interview invitation rate for Gold-signaled applicants based on AAMC post-cycle reporting; it represents an average across program tiers and applicant profiles and should not be used as a prediction for individual outcomes.

Approximate median program application counts are drawn from NRMP published data for the 2024 Main Residency Match and rounded to ranges because the published figures differ by applicant category (US MD senior, DO, IMG). Consult the NRMP Charting Outcomes reports for your applicant category for precision figures.

Frequently Asked Questions About Program Signaling

Can programs see how many total signals you sent?

No. Programs see only whether they received a signal from you and, if so, the tier (Gold or Silver). They do not see your total signal count, how many signals remain unused, or which other programs you signaled. This means there is no transparency cost to using fewer signals than your budget allows.

Can programs see which other programs you signaled?

No. Signal visibility is limited to the receiving program. A program knows it received a Gold or Silver signal from you; it does not know the identity of other programs you signaled.

Do signals expire?

Signals are specific to one application cycle. They do not carry over to a future cycle. If you reapply in a subsequent year, you start with a fresh signal allocation under that cycle's rules.

Can you change or withdraw a signal after submission?

Once the signal submission window closes, signals cannot be modified, reassigned, or withdrawn. Changes are possible within the submission window before you finalize. After the deadline, your submitted signals are final.

Can you signal a program after the deadline?

No. The signal submission window has a defined close date. Applications submitted to a program after that date do not carry signals, and signals cannot be added to previously submitted applications after the window closes.

What if a program opens after signals are submitted?

Programs that become available for application after the signal submission window has closed are not signal-eligible in that cycle under the current ERAS system. Applying to a late-opening program proceeds without signal designation. This is an architectural limitation of the current system, not a penalty.

Does signaling a program commit you to ranking it?

No. Signaling is a preference communication mechanism, not a binding commitment. You are under no obligation to rank a program you signaled, and programs cannot see your eventual rank list. Signals should reflect genuine preference at the time of application; they are not a contract.

Does signaling affect your rank list or the match algorithm?

No. The NRMP match algorithm operates entirely on submitted rank order lists. Signals do not enter the algorithm. Their effect is limited to the pre-interview screening phase—they influence whether a program invites you to interview, not what happens in the match itself.

What if you apply to more programs than your signal budget?

This is expected and common. Most applicants in competitive specialties apply to more programs than they can signal. The programs that receive no signal are not penalized in your application; they simply process your file without the signal data point. This is the baseline condition for all programs before signaling existed.

Are programs required to use signals in their screening?

No. Signaling participation is opt-in at the program level, and how programs incorporate signals into their screening workflow is not standardized. Programs that participate receive signal data but are not required to act on it in any specified way. This is why the yield effects are averages across heterogeneous program behavior, not uniform guarantees.

Data Sources and Methodology

Every quantitative claim on this page is sourced from one of the following official sources. Where figures are drawn from published reports, the data year is indicated. Where only ranges or directional patterns are reported—because AAMC or NRMP reports aggregates rather than precise point estimates at the program level—this page reflects those aggregates and avoids false precision.

Primary Sources

• AAMC ERAS Preference Signaling Program — Specialty-specific signal limit tables, applicant usage data, and post-cycle interview invitation rate analyses. Published annually by AAMC; available at aamc.org/eras. Data years used on this page: 2023–2024 and 2024–2025 application cycles where individually noted.
• NRMP Program Director Survey — Periodic survey of residency program directors on factors influencing interview and ranking decisions, including signal use. Available at nrmp.org. Most recent edition with signaling-specific questions used: 2022–2023. Readers should verify whether a more current edition has been published before their application cycle.
• NRMP Main Residency Match Data and Reports — Used for median programs applied to by specialty and applicant category. NRMP Charting Outcomes in the Match reports, published by NRMP at nrmp.org, provide precision figures stratified by applicant type. Data year: 2024 Main Residency Match.

Limitations

• Signal yield rates reported by AAMC are aggregate averages across programs and applicant profiles within a specialty. Individual program behavior varies substantially; some programs weight signals heavily in screening, others minimally. The averages mask this distribution.
• AAMC's published post-cycle data does not always break out yield rates at the program-tier level (e.g., top-20 programs vs. community programs), which limits the precision of specialty-level averages as a guide for individual decision-making.
• Applicant-type breakdowns (US MD senior vs. DO vs. IMG) are not uniformly available in published signal yield data. Where AAMC reports aggregate figures, this page presents them as aggregates; the yield effect for any individual applicant is modulated by their full application profile.
• Signal participation by specialty and program is subject to change each cycle. All figures on this page should be verified against current-cycle ERAS portal data and AAMC communications before application submission.
• Median programs applied to figures are approximate ranges derived from NRMP Charting Outcomes data across applicant categories. Precision figures by applicant type are available in the primary NRMP reports linked above.

This page will be updated each application cycle as AAMC and NRMP release new data. The data year stamp on each section identifies which cycle's data underlies that section's figures. If you are reading this in a cycle subsequent to 2024–2025, treat all specific figures as provisional until confirmed against current official publications.